Log In
BCIQ
Print this Print this
 

Integrin alpha(2) (VLA-2) (CD49B)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Integrin alpha(2) (VLA-2) (CD49B)

BCIQ
Print ChartPrint this
0 1 1 1
Phases of DevelopmentPhase I/IIPhase II
Autoimmune

1

1

Cancer

0

1




 Products Targeting Integrin alpha(2) (VLA-2) (CD49B)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$613.0M

$50.0M

$563.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today